VV

Vedant Vishwas Kunte

Active Director Director DIN 11576313
DIN 11576313 First appointment Feb 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Vedant Vishwas Kunte

Data last updated:

Vedant Vishwas Kunte is a Director at Laxonia Pharmaceutical Private Limited (since 2026) and Director at Dr. Dkind Healthcare Private Limited (since 2026).

DIN 11576313
Primary Designation Director
First Appointment 27 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Aug 20262026Active
Dr. Dkind Healthcare Private Limited U46497MR2026PTC473985
Director27 Feb 20262026Active

Directorship timeline

Open interactive timeline →
Dr. Dkind Healthcare Private Limited
Laxonia Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Vedant Vishwas Kunte

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vedant Vishwas Kunte

Vedant Vishwas Kunte currently holds 2 directorships: Laxonia Pharmaceutical Private Limited (Director, since 22 Aug 2026); Dr. Dkind Healthcare Private Limited (Director, since 27 Feb 2026).

Vedant Vishwas Kunte was first appointed on 27 Feb 2026 as Director at Dr. Dkind Healthcare Private Limited.

The current boards of Vedant Vishwas Kunte's companies include Aditya Shivaji Kunte (Laxonia Pharmaceutical Private Limited), Rutuja Ajay Fuke (Laxonia Pharmaceutical Private Limited), Shweta Narendra Thakur (Laxonia Pharmaceutical Private Limited), Vishal Rambhau Adhao (Laxonia Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available